Litigation Details for BAXTER HEALTHCARE CORPORATION v. AGILA SPECIALTIES PRIVATE LIMITED (D.N.J. 2014)
✉ Email this page to a colleague
BAXTER HEALTHCARE CORPORATION v. AGILA SPECIALTIES PRIVATE LIMITED (D.N.J. 2014)
| Docket | ⤷ Try a Trial | Date Filed | 2014-11-11 |
| Court | District Court, D. New Jersey | Date Terminated | 2016-04-20 |
| Cause | 35:271 Patent Infringement | Assigned To | Jerome B. Simandle |
| Jury Demand | None | Referred To | Joel Schneider |
| Patents | 6,310,094; 6,528,540 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in BAXTER HEALTHCARE CORPORATION v. AGILA SPECIALTIES PRIVATE LIMITED
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for BAXTER HEALTHCARE CORPORATION v. AGILA SPECIALTIES PRIVATE LIMITED (D.N.J. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-04-05 | 103 | various patents covering Baxter’s esmolol hydrochloride product, U.S. Patent Nos. 6,310,094 (hereinafter…hereinafter, “’094 Patent”) and 6,528,540 (hereinafter, “’540 Patent” and collectively, the “patents-in-suit” …subject matter to the patents-in- suit. (Compare ’094 Patent at 6:1-9, with ’540 Patent at 2:20- 29.) …reference to the ’540 Patent, U.S. Patent No. 5,017,609 (mistakenly referred as U.S. Patent No. 5,107,609) …Definition Embodied in the ’540 Patent Carries to the ’094 Patent ................................ | External link to document | |
| 2015-08-19 | 61 | Certificate of Service | Attachments: # 1 Exhibit A - U.S. Patent No. 6,310,094, # 2 Exhibit B - U.S. Patent No. 6,528,540, # 3 Certificate…2014 20 April 2016 1:14-cv-07094 830 Patent None District Court, D. New Jersey | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
